Aster DM Healthcare [ASTERDM] vs Alembic [APLLTD] Detailed Stock Comparison

Aster DM Healthcare Ltd.

NSE
Loading...

Alembic Pharmaceuticals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Aster DM Healthcare Ltd. wins in 9 metrics, Alembic Pharmaceuticals Ltd. wins in 11 metrics, with 0 ties. Alembic Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Aster DM Healthcare Ltd. Alembic Pharmaceuticals Ltd. Better
P/E Ratio (TTM) 110.37 23.42 Alembic Pharmaceuticals Ltd.
Price-to-Book Ratio 8.03 2.77 Alembic Pharmaceuticals Ltd.
Debt-to-Equity Ratio 43.79 28.00 Alembic Pharmaceuticals Ltd.
PEG Ratio -2.33 -1.77 Alembic Pharmaceuticals Ltd.
EV/EBITDA 46.61 14.29 Alembic Pharmaceuticals Ltd.
Profit Margin (TTM) 7.33% 8.66% Alembic Pharmaceuticals Ltd.
Operating Margin (TTM) 12.11% 11.37% Aster DM Healthcare Ltd.
EBITDA Margin (TTM) 12.11% 11.37% Aster DM Healthcare Ltd.
Return on Equity 147.28% 11.24% Aster DM Healthcare Ltd.
Return on Assets (TTM) 81.40% 7.51% Aster DM Healthcare Ltd.
Free Cash Flow (TTM) $683.20M $-4.76B Aster DM Healthcare Ltd.
Dividend Yield 1.05% 1.09% Alembic Pharmaceuticals Ltd.
1-Year Return 43.05% -25.60% Aster DM Healthcare Ltd.
Price-to-Sales Ratio (TTM) 8.17 2.03 Alembic Pharmaceuticals Ltd.
Enterprise Value $373.17B $161.16B Aster DM Healthcare Ltd.
EV/Revenue Ratio 8.37 2.22 Alembic Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 77.44% 71.81% Aster DM Healthcare Ltd.
Revenue per Share (TTM) $87 $371 Alembic Pharmaceuticals Ltd.
Earnings per Share (Diluted) $6.39 $32.07 Alembic Pharmaceuticals Ltd.
Beta (Stock Volatility) -0.06 0.34 Aster DM Healthcare Ltd.

Aster DM Healthcare Ltd. vs Alembic Pharmaceuticals Ltd. Stock Performance Analysis

Loading Price Chart...

ASTERDM
APLLTD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Aster DM Healthcare Ltd.-3.47%2.68%4.39%21.18%27.32%29.67%
Alembic Pharmaceuticals Ltd.-0.75%-1.04%-5.91%9.25%-14.68%-11.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Aster DM Healthcare Ltd.43.05%181.55%407.76%372.16%372.16%372.16%
Alembic Pharmaceuticals Ltd.-25.60%20.70%-23.84%41.04%1,498.60%1,498.60%

Performance & Financial Health Analysis: Aster DM Healthcare Ltd. vs Alembic Pharmaceuticals Ltd.

MetricASTERDMAPLLTD
Market Information
Market Cap i₹364.57B₹147.63B
Market Cap CategoryLarge capMid cap
10 Day Avg. Volume i556,44775,949
90 Day Avg. Volume i656,240103,405
Last Close₹786.70₹737.75
52 Week Range₹519.10 - ₹836.50₹635.80 - ₹1,107.90
% from 52W High-5.95%-33.41%
All-Time High₹836.50 (Jun 12, 2026)₹1,303.90 (Oct 07, 2024)
% from All-Time High-5.95%-43.42%
Growth Metrics
Quarterly Revenue Growth0.13%0.11%
Quarterly Earnings Growth-0.08%-0.04%
Financial Health
Profit Margin (TTM) i0.07%0.09%
Operating Margin (TTM) i0.12%0.11%
Return on Equity (TTM) i1.47%0.11%
Debt to Equity (MRQ) i43.7928.00
Cash & Liquidity
Book Value per Share (MRQ)₹87.77₹270.70
Cash per Share (MRQ)₹24.81₹7.27
Operating Cash Flow (TTM) i₹54.10B₹-3,101,700,000
Levered Free Cash Flow (TTM) i₹53.78B₹5.83B
Dividends
Last 12-Month Dividend Yield i1.05%1.09%
Last 12-Month Dividend i₹6.00₹11.00

Valuation & Enterprise Metrics Analysis: Aster DM Healthcare Ltd. vs Alembic Pharmaceuticals Ltd.

MetricASTERDM (Apr 26, 2026)APLLTD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i110.3723.42
Forward P/E i60.8017.75
PEG Ratio i-2.33-1.77
Price to Sales (TTM) i8.172.03
Price to Book (MRQ) i8.032.77
Market Capitalization
Market Capitalization i₹364.57B₹147.63B
Enterprise Value i₹373.17B₹161.16B
Enterprise Value Metrics
Enterprise to Revenue i8.372.22
Enterprise to EBITDA i46.6114.29
Risk & Other Metrics
Beta i-0.060.34
Book Value per Share (MRQ) i₹87.77₹270.70

Financial Statements Comparison: Aster DM Healthcare Ltd. vs Alembic Pharmaceuticals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricASTERDM (2025)APLLTD (2025)
Revenue/Sales i40.69B65.40B
Cost of Goods Sold i9.38B21.37B
COGS % of Revenue i23.1%32.7%
Gross Profit i31.31B44.03B
Gross Margin i76.9%67.3%
Research & Development iN/A96.00M
Operating Income (EBIT) i5.25B7.35B
Operating Margin i12.9%11.2%
EBITDA i8.75B10.52B
EBITDA Margin i21.5%16.1%
Pre-Tax Income i4.71B7.07B
Pre-Tax Income % of Revenue i11.6%10.8%
Income Tax i1.34B1.25B
Income Tax % of Revenue i3.3%1.9%
Net Income (Profit) i54.08B5.82B
Profit Margin i132.9%8.9%

Balance Sheet & Liquidity Metrics

MetricASTERDM (2025)APLLTD (2025)
Cash & Equivalents i1.65B834.80M
Total Current Assets i19.01B40.88B
Total Current Assets % of Revenue i46.7%62.5%
Total Current Liabilities i8.79B24.12B
Total Current Liabilities % of Revenue i21.6%36.9%
Long-Term Debt i18.29B467.70M
Long-Term Debt % of Revenue i45.0%0.7%
Total Shareholders Equity i36.51B51.90B
Retained Earnings i-1.52B43.94B
Retained Earnings % of Revenue i-3.7%67.2%
Property, Plant & Equipment i12.75B4.45B

Cash Flow Statement Comparison

MetricASTERDM (2025)APLLTD (2025)
Operating Cash Flow i54.10B-3.10B
Operating Cash Flow % of Revenue i132.9%-4.7%
Capital Expenditures i-3.44B-5.54B
Free Cash Flow i683.20M-4.76B
FCF Margin i1.7%-7.3%
Debt Repayment i-1.34BN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricASTERDMAPLLTD
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i516.94M196.56M
Float Shares i191.44M57.90M
% Held by Insiders i53.34%70.56%
% Held by Institutions i31.94%16.81%
% Held by Public i14.72%12.63%

Dividend Analysis & Yield Comparison: Aster DM Healthcare Ltd. vs Alembic Pharmaceuticals Ltd.

MetricASTERDMAPLLTD
Last 12-Month Dividend i₹6.00₹11.00
Last 12-Month Dividend Yield i1.05%1.09%
3-Year Avg Annual Dividend i₹41.33₹13.33
3-Year Avg Dividend Yield i11.45%1.17%
3-Year Total Dividends i₹124.00₹40.00
Ex-Dividend DateFeb 10, 2025Jul 29, 2025